In each of its application fields, ERYtech Pharma is currently encapsulating other molecules.
It also has European collaboration for the encapsulation of certain molecules.
GR-EGG1 has successfully completed in vitro and in vivo proof of concept. It consists in encapsulation of an enzyme into red blood cells for the treatment of hepatocellular carcinoma and melanoma. GR-EGG1, like GRASPA®, relies on the Cleav'ERY System®.
.
